Apellis Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.2M | 54k | 22.63 |
| 2025-03-31 | $9.3M | 424k | 22.00 |
| 2024-12-31 | $13M | 412k | 31.91 |
| 2024-09-30 | $112M | 3.9M | 28.81 |
| 2024-06-30 | $122M | 3.2M | 38.38 |
| 2024-03-31 | $130M | 2.2M | 58.78 |
| 2023-12-31 | $154M | 2.6M | 59.86 |
| 2023-09-30 | $84M | 2.2M | 38.04 |
| 2023-06-30 | $163M | 1.8M | 91.10 |
| 2023-03-31 | $100M | 1.5M | 65.52 |
| 2022-12-31 | $96M | 1.8M | 52.19 |
| 2022-06-30 | $49M | 1.1M | 45.22 |
| 2022-03-31 | $64M | 1.3M | 50.81 |
| 2021-12-31 | $75M | 1.6M | 47.27 |
| 2021-03-31 | $19M | 436k | 42.91 |
| 2020-12-31 | $36M | 632k | 57.61 |
| 2020-09-30 | $20M | 703k | 28.89 |
| 2020-06-30 | $3.3M | 101k | 32.52 |
| 2020-03-31 | $2.1M | 77k | 26.79 |
| 2019-12-31 | $13M | 427k | 30.61 |
| 2019-09-30 | $382k | 16k | 24.11 |
| 2019-06-30 | $325k | 13k | 24.48 |
| 2019-03-31 | $172k | 8.8k | 19.52 |
| 2018-12-31 | $122k | 9.2k | 13.22 |
| 2018-09-30 | $149k | 8.4k | 17.81 |
| 2018-06-30 | $1.2M | 56k | 22.00 |
| 2018-03-31 | $49k | 2.2k | 22.00 |
| 2017-12-31 | $51k | 2.3k | 21.84 |